PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
2316.00%
Net income growth above 1.5x CRK's 46.17%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-24.50%
Negative yoy D&A while CRK is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-345.92%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
-146.05%
Negative yoy working capital usage while CRK is 58.24%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
Growth well above CRK's 105.24%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
4147.62%
Some yoy increase while CRK is negative at -322.73%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-48.46%
Negative yoy CFO while CRK is 20.66%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
38.21%
Some CapEx rise while CRK is negative at -29.81%. John Neff would see competitor possibly building capacity while we hold back expansions.
-84.85%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-100.00%
Negative yoy purchasing while CRK stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-100.00%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
157.62%
Growth of 157.62% while CRK is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
155.57%
We have mild expansions while CRK is negative at -28.18%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
52.77%
Debt repayment growth of 52.77% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
-50.00%
Negative yoy issuance while CRK is 3115.79%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.